Nancy McKinstry Net Worth
Nancy McKinstry biography
Nancy McKinstry serves as Independent Director of the Company. Ms. McKinstry has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry also serves on the Board of Accenture, the Board of Overseers of Columbia Business School, and the Board of Directors of Russell Reynolds Associates. Ms. McKinstry is also a member of the European Round Table of Industrialists. Ms. McKinstry served on the Board of Directors of Telefonaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. As the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., Ms. McKinstry contributes global perspectives and management experience, including an understanding of key issues facing a multinational business such as Abbott’s.
What is the salary of Nancy McKinstry?
As the Independent Director of Abbott Laboratories, the total compensation of Nancy McKinstry at Abbott Laboratories is $316,977. There are 12 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $24,254,200.
How old is Nancy McKinstry?
Nancy McKinstry is 60, she’s been the Independent Director of Abbott Laboratories since 2011. There are 9 older and 8 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 74, who is the Independent Director.
What’s Nancy McKinstry’s mailing address?
Nancy’s mailing address filed with the SEC is C/O ACCENTURE, 161 N. CLARK STREET, CHICAGO, IL, 60601.
Insider trading at Abbott Laboratories
Over the last 19 years, insiders at Abbott Laboratories have traded over $300,124,202 worth of Abbott Laboratories stock and bought 1,026,437 units worth $44,673,718 . The most active insider traders include Miles D White, Richard A Gonzalez, and Glenn F Tilton. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,036,946. The most recent stock trade was executed by Randel William Woodgrift on 23 October 2019, trading 21,000 units of ABT stock currently worth $1,691,340.
What does Abbott Laboratories do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
What does Abbott Laboratories’s logo look like?
Abbott Laboratories executives and stock owners
Abbott Laboratories executives and other stock owners filed with the SEC include:
- Miles White, Chairman of the Board, Chief Executive Officer
- Robert Ford, President, Chief Operating Officer
- Brian Yoor, Chief Financial Officer, Executive Vice President – Finance
- Hubert Allen, Executive Vice President, General Counsel, Secretary
- Daniel Salvadori, Senior Vice President – Established Pharmaceuticals, Latin America.
- Robert Alpern, Independent Director
- Sally Blount, Independent Director
- Glenn Tilton, Independent Director
- Samuel Scott, Independent Director
- William Osborn, Lead Independent Director
- Roxanne Austin, Independent Director
- Edward Liddy, Independent Director
- Nancy McKinstry, Independent Director
- Phebe Novakovic, Independent Director
- John Stratton, Independent Director
- Daniel Starks, Independent Director
- Michelle Kumbier, Independent Director
- Darren McDew, Director
- Jaime Contreras, Senior Vice President – Core Laboratory Diagnostics, Commercial Operations
- Jared Watkin, Senior Vice President
- Andrew H Lane, Senior Vice President
- Robert E Funck, Senior Vice President
- Sean Shrimpton, Senior Vice President
- John M Capek, Executive Vice President
- Deepak S. Nath, Senior Vice President
- Joseph J Manning, Senior Vice President
- Roger Bird, Senior Vice President
- Brian J Blaser, Senior Vice President
- Stephen R Fussell, Senior Vice President
- Michael J Warmuth, Senior Vice President
- Eric S Fain, Senior Vice President
- Lisa D Earnhardt, Executive Vice President
- Sharon J Bracken, Senior Vice President
- Michael T Rousseau, Pres., Cardiovasc. & Neuromod.
- Charles Brynelsen, Senior Vice President
- Michael J Pederson, Senior Vice President
- Alejandro D Wellisch, Senior Vice President
- Sammy Karam, Senior Vice President
- Randel William Woodgrift, Senior Vice President
- Christopher J Scoggins, Senior Vice President
- Richard W Ashley, Executive Vice President
- Andrea F Wainer, Executive Vice President
- John F Ginascol, Executive Vice President
- Jean Yves Pavee, Senior Vice President
- W James Farrell, Director
- Thomas C Freyman, Senior Vice President
- Georges H. De Vos, Senior Vice President
- Katherine C. Doyle, Senior Vice President
- J. Scott White, Senior Vice President
- Charles D Foltz, Senior Vice President
- Murthy V Simhambhatla, Senior Vice President
- Thomas G Frinzi, Senior Vice President
- John C Landgraf, Senior Vice President
- Greg W Linder, Vice President
- Heather L Mason, Senior Vice President
- Paul K Magill, Senior Vice President
- A. David Forrest, Senior Vice President
- H Laurance Fuller, Director
- Carlos Alban, Senior Vice President
- James V Mazzo, Senior Vice President
- Holger A Liepmann, Senior Vice President
- William D Smithburg, Director
- Laura J Schumacher, Senior Vice President
- David Owen, Director
- Edward L Michael, Senior Vice President
- Richard A Gonzalez, Chief Operating Officer
- Donald V Jr Patton, Senior Vice President
- William M Daley, Director
- Robert B Hance, Senior Vice President
- Mary T Szela, Senior Vice President
- Roy S Roberts, Director
- Corlis D Murray, Senior Vice President
- Thomas F Chen, Senior Vice President
- Olivier Bohuon, Senior Vice President
- James L Tyree, Senior Vice President
- W Ann Reynolds, Director
- Boone Jr Powell, Director
- Mary K Moreland, Executive Vice President
- Edward J Fiorentino, Senior Vice President
- Gary E Mccullough, Senior Vice President
- Jeffrey M Leiden, President & COO
- Jack M Greenberg, Director
- Joseph M Nemmers, Senior Vice President
- John R Walter, Director
- Jeffrey R Binder, Senior Vice President
- William G Dempsey, Senior Vice President
- A Barry Rand, Director
- Thomas M Wascoe, Senior Vice President
- Christopher B Begley, Senior Vice President
- Lance B Wyatt, Senior Vice President
- Guillermo A Herrera, Senior Vice President
- Lasa Jose M De, Senior Vice President